tiprankstipranks
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
Germany Market
G49N
GenSight Biologics SA
RESEARCH TOOLSreports

GenSight Biologics SA (G49N) Financial Statements

1 Followers

GenSight Biologics SA Financial Overview

GenSight Biologics SA's market cap is currently €20.60M. The company's EPS TTM is €-0.027; its P/E ratio is -1.29; GenSight Biologics SA is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 1.00K€ 2.63M€ 1.27M€ 2.58M€ 5.28M
Gross Profit€ 0.00€ 2.63M€ 3.00M€ 2.58M€ 5.28M
Operating Income€ -11.71M€ -15.81M€ -29.70M€ -27.84M€ -28.13M
EBITDA€ -11.24M€ -14.76M€ -21.73M€ -26.77M€ -25.52M
Net Income€ -12.04M€ -14.00M€ -26.22M€ -27.62M€ -28.62M
Balance Sheet
Cash & Short-Term Investments€ 2.42M€ 2.46M€ 2.13M€ 10.61M€ 44.29M
Total Assets€ 8.26M€ 10.76M€ 9.13M€ 25.94M€ 56.65M
Total Debt€ 12.86M€ 19.11M€ 23.54M€ 12.65M€ 12.57M
Net Debt€ 10.45M€ 16.65M€ 21.40M€ 2.04M€ -31.72M
Total Liabilities€ 33.20M€ 37.68M€ 39.83M€ 41.22M€ 40.66M
Stockholders' Equity€ -24.94M€ -26.92M€ -30.67M€ -15.28M€ 15.99M
Cash Flow
Free Cash Flow€ 0.00€ -12.94M€ -24.67M€ -34.01M€ -17.17M
Operating Cash Flow€ -9.17M€ -12.94M€ -24.66M€ -33.75M€ -17.14M
Investing Cash Flow€ 180.00K€ 17.00K€ 209.00K€ 172.00K€ -16.00K
Financing Cash Flow€ 8.94M€ 13.54M€ 15.86M€ 95.00K€ 23.74M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

Income Statement >

GenSight Biologics SA Debt to Assets

Balance Sheet >

GenSight Biologics SA Cash Flow

Cash Flow >

GenSight Biologics SA Forecast EPS vs Actual EPS

Earnings >